Availability of Creon®

HPS Pharmacies wish to advise that Viatris is experiencing a supply interruption for Creon^® capsules, as follows:

Creon^® 25,000
Pancreatic extract 300 mg
ARTG 158452

 Creon^® 35,000
Pancreatic extract 420 mg
ARTG 313833 

Supplies are currently limited. While the sponsor continues to receive stock, distribution is being managed to ensure equitable access, and product availability may be unpredictable. Normal supply is expected to resume from the end of January 2027.

An internationally registered alternative of each strength has been approved for supply under Section 19A of the Therapeutic Goods Act 1989. Please note that S19A products have a longer lead time and different pricing as they must be sourced internationally.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Viatris on 1800 314 527, or your pharmacist at HPS Pharmacies.

Download PDF